CLINICAL_TRIALS
trial_result
· 2017-05-02
Clinical Trial Update: Study of the Safety and Effectiveness of Rilonacept for the Prevention of Gout Flares [Phase 2]
Summary
Phase 2 study evaluating the safety and effectiveness of rilonacept for preventing gout flares completed; results were posted May 2, 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Regeneron Pharmaceuticals | Conditions: Gout | Phase 2 | Status: COMPLETED | Results posted: 2017-05-02